PROGRAMMA FINALE - ABSTRACTS ONLINE

PhD POSTER SESSIONS ABSTRACTS

PhD Poster Sessions
D-2 PAIN PHARMACOLOGY, BEHAVIOURAL PHARMACOLOGY AND TOXICOLOGY, DRUGS OF ABUSE, PHARMACOLOGY OF METABOLISM AND ENDOCRINE SYSTEM, OSTEOARTICULAR PHARMACOLOGY, PHARMACOLOGY OF INFLAMMATION, ANTINEOPLASTIC DRUGS, IMMUNOPHARMACOLOGY AND VACCINES, PHARMACOVIGILANCE AND PHARMACOEPIDEMIOLOGY, EXPERIMENTAL AND CLINICAL TOXICOLOGY, PHARMACOGENETICS, PHARMACOGENOMICS AND GENE THERAPY

D-2/1 Investigation on dynorphin and BDNF role in an experimental model of neuropathic pain
D. Mercatelli ( Bologna)
D-2/2 Oxaliplatin-induced neuropathy: oxidative mechanisms in nervous cells.
M. Zanardelli (Firenze)
D-2/3 Social behavior and fear response to predator in zebrafish: Role of oxytocin/vasopressin system
R. Martucci (Milano)
D-2/4 Abnormal EEG and memory associative deficit in SNAP-25 heterozygous mice
A. Donzelli (Milano)
D-2/5 Long-lasting depressive and anxiogenic-like effects in adolescent male rats chronically treated with Nandrolone
S. Speziali ( Busto Arsizio)
D-2/6 Short and long-term effect of delta-9-tetrahydrocannabinol on immune function in mice
S. Moretti (Milano)
D-2/7 Lysozyme, a multi-role regulatory protein, as chemopreventive drug in the diabetic nephropathy
D. Gallo ( Trieste)
D-2/8 Deletion of TRPV1 gene decreases osteoclast activity and protects from ovariectomy-induced bone loss
S. Mancusi ( Napoli)
D-2/9 The effects of Oleuropein aglycone, an olive oil compound, on acute and chronic inflammation
D. Impellizzeri ( Messina)
D-2/10 Differential roles of microsomal Prostaglandin E Synthase-1 inmurine colitis
A. Bruno ( Chieti)
D-2/11 Genotype-guided phase I study for weekly paclitaxel in ovarian cancer patients
S. Boffo (Aviano (PN))
D-2/12 Functionalized fullerenes as nanocarriers for anticancer drugs
M. Lucafò ( Trieste)
D-2/13 Generation of Small Cell Lung Cancer(SCLC) bioluminescent xenograft orthotopic mouse models and evaluation of anti-tumoral activity of different chemoterapic agents.
M. Ruocco (Bologna)
D-2/14 Effects of human IgG on HUVECs: a molecular approach to the understanding of the therapeutic efficacy of IgG administration in vivo.
G. Frigo (Padova)
D-2/15 Triptans and cardiovascular events: data mining of the FDA Adverse Event Reporting System (AERS)
G. Roberto ( Bologna)
D-2/16 CYP1A2 induction in liver cirrhosis
D. Gabbia (Padova)
D-2/17 Effects of Cabbage sprout extract on xenobiotic metabolizing enzymes of Sprague-Dawley rat liver.
S. Melega (Bologna)
D-2/18 3D-cell-sheets from a continuous, stable, non-tumorigenic, mesenchymal stem cell line derived from rat dental pulp: an innovative tool for toxicological tests.
F. Di Scipio (Torino)
D-2/19 Effects of Lisosan G on antioxidant and xenobiotic-metabolising enzymes in primary rat hepatocytes cultures
M. La Marca ( pisa)
D-2/20 Design and development of pharmacogenetic molecular tests
E. Bugin (Padova)
D-2/21 Mitochondrial Pharmacogenomics: How does the mitochondrion react to drugs?
D. Strobbe (Bologna)
D-2/22 Denaturing High-Performance Liquid Chromatography Method for the Identification of Variant of Cytochrome P450 2D6
L. Bertolaso (Padova)